Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Covens

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|February 28, 2024
The role of surgeon specialty in management and survival of malignant ovarian germ cell tumors: A population-based studyLina Salman, Allan Covens, Danielle Vicus, et al.
Gynecologic Oncology|April 2, 2002
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancerAllan Covens, Mark Carey, Peter Bryson, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 17, 2006
Cyclooxygenase-2 (COX-2) immunostaining does not correlate with the degree of vulvar neoplasiaSharon Nofech-Mozes, Rachel Kupets, Golnar Rasty, et al.
Cancer|September 29, 2004
Systematic review of adjuvant care for women with Stage I ovarian carcinomaLaurie Elit, Alexandra Chambers, Anthony Fyles, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 14, 2024
Assessing para-aortic nodal status in high-grade endometrial cancer patients with negative pelvic sentinel lymph node biopsyAnouk Benseler, Danielle Vicus, Allan Covens, et al.
Gynecologic Oncology|November 21, 2018
Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumorsAndra Nica, Allan Covens, Danielle Vicus, et al.
Gynecologic Oncology|May 31, 2014
Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?Geneviève Bouchard-Fortier, William H Geerts, Allan Covens, et al.
Gynecologic Oncology|June 12, 2003
Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group studyAllan Covens, Virginia L Brunetto, Maurie Markman, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
The Relation Between Post-Operative Surgical Site Infection and Time to Start Adjuvant Treatment in Ovarian and Uterine CancersKarlijn M C Cornel, Julie My Van Nguyen, Lilian T Gien, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 30, 2019
Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenterationSoyoun Rachel Kim, Yoo-Young Lee, Harinder Brar, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|February 28, 2024
The role of surgeon specialty in management and survival of malignant ovarian germ cell tumors: A population-based studyLina Salman, Allan Covens, Danielle Vicus, et al.
Gynecologic Oncology|April 2, 2002
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancerAllan Covens, Mark Carey, Peter Bryson, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 17, 2006
Cyclooxygenase-2 (COX-2) immunostaining does not correlate with the degree of vulvar neoplasiaSharon Nofech-Mozes, Rachel Kupets, Golnar Rasty, et al.
Cancer|September 29, 2004
Systematic review of adjuvant care for women with Stage I ovarian carcinomaLaurie Elit, Alexandra Chambers, Anthony Fyles, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 14, 2024
Assessing para-aortic nodal status in high-grade endometrial cancer patients with negative pelvic sentinel lymph node biopsyAnouk Benseler, Danielle Vicus, Allan Covens, et al.
Gynecologic Oncology|November 21, 2018
Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumorsAndra Nica, Allan Covens, Danielle Vicus, et al.
Gynecologic Oncology|May 31, 2014
Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?Geneviève Bouchard-Fortier, William H Geerts, Allan Covens, et al.
Gynecologic Oncology|June 12, 2003
Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group studyAllan Covens, Virginia L Brunetto, Maurie Markman, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
The Relation Between Post-Operative Surgical Site Infection and Time to Start Adjuvant Treatment in Ovarian and Uterine CancersKarlijn M C Cornel, Julie My Van Nguyen, Lilian T Gien, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 30, 2019
Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenterationSoyoun Rachel Kim, Yoo-Young Lee, Harinder Brar, et al.
Pageof 11